Background Medication-related osteonecrosis of the jaw (MRONJ), which was first reported
as bisphosphonate-related osteonecrosis of the jaw (BRONJ) in bisphosphonate users, is a …

Context Antiresorptive therapy significantly reduces fracture risk in patients with benign bone
disease and skeletal-related events (SREs) in patients with bone metastases (BM) …

PURPOSE To provide guidance regarding best practices in the prevention and
management of medication-related osteonecrosis of the jaw (MRONJ) in patients with …

Medication-related osteonecrosis of the jaw (MRONJ) is one of the most interesting diseases
in the field of maxillofacial surgery. In addition to bisphosphonates, the use of antiresorptive …

The integration and long-term success of dental implants exploit the unique biology of the
oral cavity, which allows for osseous incorporation of a biomaterial and its long-term health …

Ethanol influenced microwave-assisted extraction was performed for obtaining of natural
antioxidants from spent filter coffee. The process included response surface methodology …

Considering the lack of studies determining the real TPTD efficacy in individuals who
develop MRONJ, our objective was to combine the available data on MRONJ cases treated …

Medication-related osteonecrosis of the jaw (MRONJ) is a rare but detrimental intraoral
lesion that predominantly occurs in patients with long-term use of antiresorptive agents, such …

Background: Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of
bisphosphonates and anti-resorptive drugs prescribed for treatment of severe osteoporosis …

Abstract Background Medication-Related Osteonecrosis of the Jaws (MRONJ) incidence are
increasing among elderly. Treatment can be challenging. Prevent or treatment protocols that …